Agios Pharmaceuticals, Inc. 0HB0.L Stock
Agios Pharmaceuticals, Inc. Price Chart
Agios Pharmaceuticals, Inc. 0HB0.L Financial and Trading Overview
| Agios Pharmaceuticals, Inc. stock price | 37.65 USD |
| Previous Close | 25.68 USD |
| Open | 0 USD |
| Bid | 0 USD x N/A |
| Ask | 0 USD x N/A |
| Day's Range | 0 - 0 USD |
| 52 Week Range | 0 - 34.57 USD |
| Volume | 30 USD |
| Avg. Volume | 185 USD |
| Market Cap | 11.54M USD |
| Beta (5Y Monthly) | 0.940492 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -6.426 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
0HB0.L Valuation Measures
| Enterprise Value | 753.17M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.6067833 |
| Price/Book (mrq) | 1.3599024 |
| Enterprise Value/Revenue | 39.605 |
| Enterprise Value/EBITDA | -2.032 |
Trading Information
Agios Pharmaceuticals, Inc. Stock Price History
| Beta (5Y Monthly) | 0.940492 |
| 52-Week Change | 35.22% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 34.57 USD |
| 52 Week Low | 0 USD |
| 50-Day Moving Average | 26.89 USD |
| 200-Day Moving Average | 26.95 USD |
0HB0.L Share Statistics
| Avg. Volume (3 month) | 185 USD |
| Avg. Daily Volume (10-Days) | 100 USD |
| Shares Outstanding | 58.18M |
| Float | 51.4M |
| Short Ratio | N/A |
| % Held by Insiders | 1.35% |
| % Held by Institutions | 109.02% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1990.40% |
| Gross Margin | 104.74% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -19.023% |
| Return on Equity (ttm) | -19.43% |
Income Statement
| Revenue (ttm) | 19.02M USD |
| Revenue Per Share (ttm) | 0.35 USD |
| Quarterly Revenue Growth (yoy) | 574.20% |
| Gross Profit (ttm) | 12.54M USD |
| EBITDA | -370639008 USD |
| Net Income Avi to Common (ttm) | -218044992 USD |
| Diluted EPS (ttm) | -6.426 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 739.2M USD |
| Total Cash Per Share (mrq) | 13.3 USD |
| Total Debt (mrq) | 82.34M USD |
| Total Debt/Equity (mrq) | 7.94 USD |
| Current Ratio (mrq) | 17.548 |
| Book Value Per Share (mrq) | 18.662 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -306926016 USD |
| Levered Free Cash Flow (ttm) | -190762880 USD |
Profile of Agios Pharmaceuticals, Inc.
| Country | United Kingdom |
| State | MA |
| City | Cambridge |
| Address | 88 Sidney Street |
| ZIP | 02139 |
| Phone | 617 649 8600 |
| Website | https://www.agios.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 389 |
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism. The company develops PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes for the treatment of hemolytic anemias; and AG-946, a PK activator for treating lower-risk myelodysplastic syndrome and hemolytic anemias. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
Q&A For Agios Pharmaceuticals, Inc. Stock
What is a current 0HB0.L stock price?
Agios Pharmaceuticals, Inc. 0HB0.L stock price today per share is 37.65 USD.
How to purchase Agios Pharmaceuticals, Inc. stock?
You can buy 0HB0.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Agios Pharmaceuticals, Inc.?
The stock symbol or ticker of Agios Pharmaceuticals, Inc. is 0HB0.L.
How many shares does Agios Pharmaceuticals, Inc. have in circulation?
The max supply of Agios Pharmaceuticals, Inc. shares is 454.68K.
What is Agios Pharmaceuticals, Inc. Price to Earnings Ratio (PE Ratio)?
Agios Pharmaceuticals, Inc. PE Ratio is now.
What was Agios Pharmaceuticals, Inc. earnings per share over the trailing 12 months (TTM)?
Agios Pharmaceuticals, Inc. EPS is -6.426 USD over the trailing 12 months.